Vaughn's Summaries logo Vaughn's Summaries

Medicine Summaries
Losing Weight

Prescription Drug Sales
Top Selling U.S. Medications List

Here is a summary of 2008 U.S. prescription drug sales, for the 30 top selling drugs, compared with 2003, 2004, 2005, 2006 and 2007 U.S. drug sales.


Comparing a drug's sales year-over-year CAN indicate a drug that is being phased out due to severe side effects, and/or inefficacy.

30

390 - 450

30

.
2003, 2004, 2005, 2006, 2007 and 2008
Top U.S. Prescription Drug Sales List - Comparison Chart

2003
Sales Rank
2004
Sales Rank
2005
Sales Rank
2006
Sales Rank
2007
Sales Rank
2008
Sales Rank

Drugs Listed
by 2007 Sales

.
2006
World-Wide
Sales

  Primary Use
    (# of complaints)

Company

.
Location

1

1
1
1
1
1

Lipitor

$ 14,300 M

cholesterol (1,367)

Pfizer

New York, NY

5

4

2
2
2
2

Nexium

$ 5,100 M

heartburn

AstraZeneca

London, Eng.

12

7

7
7
5
3

Plavix

$ 6,000 M

anticoagulant

Bristol-Myers Squibb

New York, NY

11

8

5
4
3
4

Advair Diskus

$ 6,100 M

asthma

GlaxoSmithKline

London, Eng.

3

3

3
3
4
5

Prevacid

$ 3,400 M

heartburn

TAP Pharma

Lake Forest, IL

32
19
14
11
7
6

Seroquel

$ 3,500 M

depression - (148)

AstraZeneca

London, Eng.

23
16
9
5
6
7

Singulair

$ 3,500 M

asthma - (2,426)

Merck

Whitehouse Station, NJ

14
13
8
6
8
8

Effexor

$ 3,700 M

depression

Wyeth

Madison, NJ

20
25
24
51
33
9

Oxycontin

-

pain

Purdue Pharma

Stamford, CT

55

31
13
10
9
11

Lexapro

$ 2,600 M

depression

Forest Labs.

Commack, NY

29
26
15
14
10
10

Actos

$ 2,800 M

diabetes

Takeda Pharma.

Osaka, Japan

16
14
11
12
11

68

Protonix

$ 3,600 M

heartburn

Wyeth

Madison, NJ

>200

>200

49
22
12
18

Vytorin

$ 1,900 M

cholesterol

Merck

Whitehouse Station, NJ

49
43
25
20
13
13

Topamax

$ 2,000 M

migraine - (679)

Johnson & Johnson

New Brunswick, NJ

17
18
18
18
14
28

Risperdal

$ 4,100 M

schizophrenia

Johnson & Johnson

New Brunswick, NJ

111

53
29
24
15
12

Abilify

$ 1,900 M

schizophrenia

Otsuka Pharma.

Tokushima, Japan

>200

>200

61
35
16
14

Cymbalta

$ 1,300 M

depression

Eli Lilly

Indianapolis, IN

75

54
34
26
17
19

Lamictal

$ 1,800 M

epilepsy - (322)

GlaxoSmithKline

London, Eng.

6

9

16
19
18
15

Zyprexa

$ 4,300 M

schizophrenia

Eli Lilly

Indianapolis, IN

25
29
20
25
19
22

Levaquin

$ 1, 500 M

antibiotic - (2,358)

Johnson & Johnson

New Brunswick, NJ

8

10

26
27
20

20

Celebrex

$ 2,000 M

arthritis

Pfizer

New York, NY

126

68
39
32
21

30

Zetia

$ 1, 900 M

cholesterol

Merck

Whitehouse Station, NJ

72

61
36
31
22
16

Valtrex

$ 1,500 M

herpes

GlaxoSmithKline

London, Eng.

>200

88
51
37
23
17

Crestor

$ 2,000 M

cholesterol

AstraZeneca

London, Eng.

21
20
17
23
24

133

Fosamax

$ 3,100 M

osteoporosis (155)

Merck

Whitehouse Station, NJ

33
39
31
29
25

>200

Zyrtec

$ 2,300 M

allergy

Pfizer

New York, NY

109

78
46
38
26
21

Lantus

$ 2,000 M

diabetes

Sanofi-Aventis

Paris, France

90

69
35
33
27
23

Adderall XR

$ 900 M

amphetamine

Shire Pharma.

Hampshire, Eng.

>200

>200

>200

52
37
24

Lyrica

-

antiseizure

Pfizer

New York, NY

65

57
43
39
28
25

Diovan

$ 4,200 M

hypertension (100)

Novartis

Basel, Swit.

79

63
45
40
30
26

Tricor

$ 1,500 M

cholesterol

Abbott Labs.

Abbott Park, IL

71
73
59
47
36
27

Flomax

-

urinary - (120)

Boehringer-Ingelheim

Ingleheim, Ger.

83
73
48
42
32
29

Diovan HCT

-

hypertension

Novartis

Basel, Swit.

2003
2004
2005
2006
2007
2008

-
-

>200

>200

>200

13

41

>200

Ambian

$ 2,545 M

insomnia - (166)

Sanofi-Aventis

Paris, France

36
36
19
17

29

76

Avandia

$ 3,043 M

diabetes

GlaxoSmithKline

London, Eng.

41
33
27
36

46

48

Enbrel

$ 4,379 M

arthritis

Wyeth

Madison, NJ

>200

>200

>200

59

47

32

Spiriva

$ 1,735 M

bronchospasm

Boehringer-Ingelheim

Ingleheim, Ger.

13
15

10

9

52

>200

Norvasc

$ 4,866 M

hypertension - Pfizer

These drugs fell into disfavor in 2007.

68

74
60
56

59

54

Cozaar/ Hyzaar

$ 3,163 M

hypertension - Merck

35
30
77
58

53

40

Lovenox

$ 3,059 M

anticoagulant - Sanofi

160

148

115

101

99

87

Gleevec/ Glivec

$ 2,554 M

leukemia - Novartis

4

5

85
88

105

118

Procrit

$ 3,180 M

anemia - J&J

>200

155
76
76
76

109

Yasmin 28

-

birth control (4,799)

>200

107
84
79

162

85

Humira

$ 2,044 M

arthritis - Abbott

7

6

6

15

170

>200

Zoloft

$ 2,110 M

depression - Pfizer (271)

2

2

4

8

>200

>200

Zocor

$ 2,803 M

cholesterol - Merck (487)

These drugs have fallen off the map.
Once thought good, where are they now?

28
22

>200

>200

>200

>200

Remicade

$ 4,428 M

Crohn's Disease - J&J

46
17

187

168

>200

>200

Aranesp

$ 4,121 M

anemia - Amgen

37
38

>200

>200

>200

>200

MabThera/ Rituxan

$ 3,861 M

cancer - Genentech

120

106

>200

>200

>200

>200

Herceptin

$ 3,134 M

breast cancer - Roche

40
24

>200

>200

>200

>200

Neulasta

$ 2,710 M

chemotherapy - Amgen

9

12

>200

>200

>200

>200

Epogen

$ 2,511 M

anemia - Amgen

>200

183

>200

>200

>200

>200

Avastin

$ 2,364 M

cancer - Roche

58
67

>200

>200

>200

>200

Prevnar

$ 1,961 M

vaccine - Wyeth

10

11

123

>200

>200

>200

Neurontin

-

seizures - Pfizer

18
21
22
65

>200

>200

Pravachol

-

cholesterol - Bristol-M.

38
32
62
98

>200

128

Duragesic

-

pain - Janssen

39

124

147

159

>200

>200

Prilosec

-

heartburn - Astrazenica

62
58
98

105

>200

>200

Paxil

-

depression - GSK (188)

19
37

>200

>200

>200

>200

Vioxx

-

pain - Merck

158

149

>200

>200

>200

>200

lisinopril

-

hypertension -
Teva - (2,148)

>200

>200

>200

>200

>200

>200

Mirena

-

birth control (3,398)

2003
2004
2005
2006
2007
2008

(xxx) above refers to the number of side effect complaints at
medications.com

  Red = Sales drop from previous year
  Green = Sales increase from previous year
  >200 = Drugs that have shrunk in sales

2003 Data Source: http://www.drugs.com/top200_2003.html
2004 Data Source:
http://www.drugs.com/top200_2004.html
2005 Data Source:
http://www.drugs.com/top200_2005.html
2006 Data Source:
http://www.drugs.com/top200_2006.html
2007 Data Source: http://www.drugs.com/top200_2007.html
2008 Data Source: http://www.drugs.com/top200.html

Other World-Wide Sales Data-
2004 -
www.pharmalive.com/special&endash;reports/sample.cfm?reportID=191
2005 - Forbes.com (IMS Health, Feb. 2006)
2006 Data Source (old):
Pharm Exec 50, May 1, 2007 - Link expired
2006 Data Source (new): Wiki - WW List_of_bestselling_drugs (2006)

50

50

50

50

50

120

90

150

130

170


top of page

Disclaimer
The author is not a doctor.
NO medical advice is offered or implied.
Statements on this page may NOT be correct.
These are just my personal observations and opinions.
The sole purpose of this page is to encourage further research on your part.

I hope that you have found this drug sales information page helpful.
Thank you very much for your time.




Vaughn's Summaries
©2009 Vaughn Aubuchon
www.vaughns-1-pagers.com
All Rights Reserved
This Vaughns Top Prescription Drug Sales Summary Chart
was last updated on 2012-07-21.